我要投票 Highchange汉臣氏在益生菌行业中的票数:393
· 外 推 电 报 ·
2025-08-24 18:27:17 星期日

【Highchange汉臣氏是哪个国家的品牌?】

Highchange汉臣氏是什么牌子?「Highchange汉臣氏」是汉臣氏(沈阳)儿童制品有限公司旗下著名品牌。该品牌发源于辽宁,由创始人成方争在2008-04-28期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Highchange汉臣氏品牌出海!将品牌入驻外推网,定制Highchange汉臣氏品牌推广信息,可以显著提高Highchange汉臣氏产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

法国汉臣氏集团是专业致力于打造孕妇及儿童健康产业品牌的复合型企业,旗下产品领域涵盖:以食疗为主的儿童健康产品系列、儿童生物制品系列、儿童护肤制品系列、儿童智能开发玩具系列及儿童教育系列及孕妇系列。

法国汉臣氏集团遵循着“一切以用户为中心”的经营方针,坚持产品的高科技投入及高速创新。2005年汉臣氏集团在中国市场上首次推出了以食疗为主的儿童类产品,产品采用先进生物提炼技术、萃取技术、浓缩技术等,均居于行业领先地位。

汉臣氏系列产品由56位专家,历时6年,针对中国儿童不同阶段生理特点,专为婴幼儿及儿童设计的高科技系列产品,让中国宝宝更健康。

汉臣氏系列产品在GMP环境下生产,全程电脑无菌操作(采用臭氧、微波等仪器杀菌),严格控制有害物质进入,确保每盒汉臣氏产品无毒、安全、温和,可长期服用无任何副作用。

汉臣氏系列产品采用天然高品质原料及国际最新生产工艺(如优良菌种化技术、超低温冷冻干燥技术、第四代生物螯合技术等),安全起效,吸收好,不会引起上火、胃胀、消化不良、便秘等不良反应。

公司自成立以来,采取有力措施,从一个品牌到现在的多个主打品牌,充分体现了汉臣氏企业的生机和活力,逐步通过由低端品牌技术向高端品牌技术过渡、由区域市场竞争向全国市场竞争过渡,使企业从传统管理走向现代管理、从产品经营走向品牌经营。

公司秉承“高标准,零缺陷”的市场理念,求真务实,先后推出“汉臣氏”品牌、“A+”系列品牌、“孕邦”系列、“三好宝贝”系列等品牌,形成了以研发、生产、销售、服务等多元发展的规模化现代企业。

未来公司的发展将以“创新品牌、完善产品、高效服务、科学管理”为经营理念,依托国际技术合作平台,按照用户需求,精心打造用户满意的大品牌,构建一个拥有牢固信誉的产品市场体系。

今后公司仍将一如既往地与各界朋友开展广泛、真诚的合作,并欢迎各位与我们一道,共商业务合作,共寻发展机遇,实现双赢。

长久以来,汉臣氏集团在同行业领域中树立了良好的信誉和品牌形象,知名度和信任度也承受之不断的提升,一举跻身于中国儿童产业的主流地位。同时,汉臣氏亦热心投身于社会公益和慈善事业,造福社会,并获得多种荣誉称号。

英文翻译:French Hansen group is a compound enterprise specialized in building the brand of pregnant women and children's health industry. Its product fields include: Children's health product series, children's biological product series, children's skin care product series, children's intelligent development toy series, children's education series and pregnant women's series. Henderson group of France follows the management policy of "customer-oriented", insisting on high-tech investment and high-speed innovation of products. In 2005, Hanchen group launched its children's products mainly for dietotherapy in the Chinese market for the first time. The products adopt advanced biological extraction technology, extraction technology, concentration technology, etc., which are all in the leading position in the industry. Hanchen's series products are designed by 56 experts for 6 years, aiming at the physiological characteristics of Chinese children at different stages. They are high-tech series products specially designed for infants and children to make Chinese babies healthier. Hansen's products are produced in GMP environment, the whole process of computer aseptic operation (using ozone, microwave and other instruments for sterilization), strictly control the entry of harmful substances, ensure that each box of Hansen's products is non-toxic, safe and mild, and can be taken for a long time without any side effects. Hanchen series products adopt natural high-quality raw materials and the latest international production technology (such as excellent spawning technology, ultra-low temperature freeze drying technology, the fourth generation of biological chelating technology, etc.), which are safe and effective, well absorbed, and will not cause adverse reactions such as burning, stomach distention, indigestion, constipation, etc. Since its establishment, the company has taken effective measures to fully embody the vitality and vitality of Hanchen's enterprises from one brand to several major brands. Gradually, through the transition from low-end brand technology to high-end brand technology, from regional market competition to national market competition, the company has moved from traditional management to modern management and from product management to brand management. Adhering to the market concept of "high standard, zero defect", the company has successively launched "Hanshen" brand, "a +" series brand, "pregnant state" series, "three good babies" series brand, forming a modern enterprise with diversified development of R & D, production, sales, service, etc. In the future, the company's development will take "innovation of brand, improvement of product, efficient service and scientific management" as the business philosophy, rely on the international technical cooperation platform, carefully build a large brand of user satisfaction according to user needs, and build a product market system with solid reputation. In the future, the company will continue to carry out extensive and sincere cooperation with friends from all walks of life. You are welcome to join us to discuss business cooperation, seek development opportunities and achieve win-win. For a long time, Hansen group has established a good reputation and brand image in the same industry, and its popularity and trust have been constantly improved, and it has become the mainstream of China's children's industry. At the same time, Hanchen also devoted himself to social welfare and charity, benefiting the society, and won various honorary titles.

本文链接: https://www.waitui.com/brand/ee0170494.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格林美:筹划发行H股股票并在香港联交所上市

36氪获悉,格林美发布公告,经充分研究论证,董事会同意公司发行H股股票并在香港联合交易所有限公司(简称“香港联交所”)主板挂牌上市。公司将充分考虑现有股东的利益和境内外资本市场的情况,在股东会决议有效期内(即经公司股东会审议通过之日起24个月或同意延长的其他期限)选择适当的时机和发行窗口完成本次发行上市。截至目前,公司正积极与相关中介机构就本次发行上市的相关工作进行商讨,除本次董事会、监事会审议通过的相关议案外,其他关于本次发行上市的具体细节尚未最终确定。

28分钟前

中信证券:预计未来中国前列腺癌RDC诊疗市场将超100亿元

36氪获悉,中信证券研报表示,创新核药RDC有望解决目前前列腺癌诊疗过程中检测负担大、疗效有限等未被满足临床需求,改变前列腺癌诊疗范式,实现诊疗一体化,提高患者依从性和生存期。目前中国尚无任何RDC上市,市场呈现蓝海状态,海外前列腺癌RDC诊疗产品在2021年上市,2024年市场已接近30亿美元,充分验证了其巨大的商业价值。中信证券认为中国有望复刻海外前列腺癌RDC诊疗市场发展路径,预计未来中国前列腺癌RDC诊疗市场将超100亿元,市场呈现高速增长状态。该行业关键点为核素、配体分子形态、生产配送能力,建议关注在上述条件具有优势的公司。

28分钟前

​锡业股份:上半年净利润10.62亿元,同比增长32.76%

36氪获悉,锡业股份披露2025年半年报,上半年实现营业收入210.93亿元,同比增长12.35%;归属于上市公司股东的净利润10.62亿元,同比增长32.76%;基本每股收益0.626元。

28分钟前

亚世光电:上半年净利润538.04万元,同比下降36.21%

36氪获悉,亚世光电披露2025年半年报,上半年实现营业收入4.32亿元,同比增长30.01%;归属于上市公司股东的净利润538.04万元,同比下降36.21%;基本每股收益0.0331元。

28分钟前

金螳螂:上半年净利润3.58亿元,同比增长3.95%

36氪获悉,金螳螂披露2025年半年报,上半年实现营业收入95.28亿元,同比增长2.49%;归属于上市公司股东的净利润3.58亿元,同比增长3.95%;基本每股收益0.1348元。

28分钟前

本页详细列出关于Highchange汉臣氏的品牌信息,含品牌所属公司介绍,Highchange汉臣氏所处行业的品牌地位及优势。
咨询